RECRUITING

Improving Cognition and Behavior in Pediatric Cancer Survivors Using a Novel Mindful Attention Training

Talk to us

Conditions

Pediatric CancerPediatric Cancer SurvivorAttentionCognitive Control

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This pilot study will evaluate the cognitive and behavioral outcomes of using a novel, adaptive attention training in pediatric cancer survivors.

Official Title

A Pilot Study of Assessing and Improving Cognition and Real-World Behavior in Pediatric Cancer Survivors

Quick Facts

Study Start:2023-03-20
Study Completion:2025-05-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05000905

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:7 Years to 17 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. 1. Age 7-17 at the time of enrollment.
  2. 2. Able to understand study procedures and to comply with them for the entire length of the study.
  3. 3. Ability of individual and legal guardian/representative to understand a written informed consent document, and the willingness to sign it.
  4. 4. Normal or corrected-normal vision and hearing.
  5. 5. English language fluency (minor participant and parent/guardian).
  6. 6. Received radiation therapy to the brain or neck between age 7-17.
  7. 7. Patients not on current cancer-related treatment (except supportive care) or those on other current treatments that would not hinder study participation. Patients currently on cancer-related treatments will be discussed with the study team (co-PI Mueller).
  1. 1. Contraindication to any study-related procedure or assessment.
  2. 2. Motor/perceptual difficulties that prevent computer or tablet use.
  3. 3. Current cancer-related treatments that would impact the ability to participate in the study (e.g., current inpatient chemotherapy or intrathecal chemotherapy). Patients on other current treatments will be discussed with the study team (co-PI, Dr. Mueller)

Contacts and Locations

Study Contact

Joaquin Anguera, PhD
CONTACT
877-827-3222
engage.pcs@ucsf.edu

Principal Investigator

Joaquin Anguera, PhD
PRINCIPAL_INVESTIGATOR
University of California, San Francisco

Study Locations (Sites)

Univeristy of California, San Francisco
San Francisco, California, 94143
United States

Collaborators and Investigators

Sponsor: University of California, San Francisco

  • Joaquin Anguera, PhD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-03-20
Study Completion Date2025-05-31

Study Record Updates

Study Start Date2023-03-20
Study Completion Date2025-05-31

Terms related to this study

Keywords Provided by Researchers

  • Pediatric Cancer Survivor
  • Attention
  • Cognitive Control

Additional Relevant MeSH Terms

  • Pediatric Cancer